Fragkiski Fragkiskatou

Mr. Fragkiski Fragkiskatou

Pharmacology, National and Kapodistrian University of Athens, Athens, Attikí, Greece

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
IFIoanna Farmakioti
Ioanna Farmakioti
ESElectra Stylianopoulou
Electra Stylianopoulou
NSNikistratos Siskos
Nikistratos Siskos
Evangelia KaragianniEvangelia Karagianni
Evangelia Karagianni
DKDionysios Kandylas
Dionysios Kandylas
MGMaria Grigoriou
Maria Grigoriou
Background: Over the past decade, probiotics have gained increasing recognition for their health benefits to the host. While most research has focused on the therapeutic effects of probiotics in the treatment of various diseases, recent years have seen a shift towards exploring their role in enhancing and supporting overall health. Methods: In this work, we have studied the effects of a novel potential probiotic strain, Lactiplantibacillus pentosus PE11, in healthy mice following a six-week dietary intervention. The assessment included monitoring the general health of the animals, biochemical analyses, profiling of the gut and fecal microbial communities, and gene expression analysis. Results: Our results showed that the administration of Lactiplantibacillus pentosus PE11 led to changes in the composition of the fecal microbiome, specifically an increase in the Firmicutes/Bacteroidetes ratio and in the relative abundance of the Lachnospiraceae, Ruminococcaceae, and Rikenellaceae families. Reduced Tnf expression and elevated Zo1 expression were also observed in the cecum, pointing to anti-inflammatory properties and improved intestinal barrier integrity. Additionally, a significant reduction in triglycerides and alanine aminotransferase levels—within physiological ranges—was observed, along with a trend toward decreased total cholesterol levels. Conclusions: These findings suggest that in healthy mice, Lactiplantibacillus pentosus PE11 has the potential to positively influence gut microbiome structure and metabolism, thereby supporting improved overall health.

9 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
IFIoanna Farmakioti
Ioanna Farmakioti
ESElectra Stylianopoulou
Electra Stylianopoulou
NSNikistratos Siskos
Nikistratos Siskos
Evangelia KaragianniEvangelia Karagianni
Evangelia Karagianni
DKDionysios Kandylas
Dionysios Kandylas
MGMaria Grigoriou
Maria Grigoriou
Over the past decade, probiotics have gained increasing recognition for their health benefits to the host. While most research has focused on the therapeutic effects of probiotics in the treatment of various diseases, recent years have seen a shift towards exploring their role in enhancing and supporting overall health. In this work, we have studied the effects of a novel potential probiotic strain, Lactiplantibacillus pentosus PE11, in healthy mice following a six-week dietary intervention. The assessment included monitoring the general health of the animals, biochemical analyses, profiling of the gut and fecal microbial communities and gene expression analysis. Our results showed that the administration of Lactiplantibacillus pentosus PE11 led to significant changes in the composition of the fecal microbiome, specifically an increase in the Firmicutes/Bacteroidetes ratio and in the relative abundance of the Lachnospiraceae, Ruminococcaceae and Rikenellaceae families. Additionally, a significant reduction in triglyceride and alanine aminotransferase levels was observed, along with a trend toward decreased total cholesterol levels. Our results suggest that in healthy mice Lactiplantibacillus pentosus PE11 has the potential to positively influence gut microbiome structure and metabolism, thereby supporting improved overall health.